Nikolaos Kelekis

National and Kapodistrian University of Athens

Papers

1

Total Citations

15

H-Index

1

About

Nikolaos Kelekis is a leading figure in interventional oncology, with a research focus that bridges minimally invasive ablation techniques and surgical oncology for the treatment of solid tumors, particularly renal cell carcinoma. His major contributions lie in advancing percutaneous microwave ablation as a viable, nephron-sparing alternative to robotic surgery, offering patients reduced morbidity without compromising oncologic outcomes. In a landmark 2024 propensity-matched cohort study, Kelekis demonstrated that microwave ablation achieves comparable long-term oncologic control to robot-assisted partial nephrectomy for stage I renal cancer, a finding with significant implications for clinical decision-making. This work, already garnering 15 citations shortly after publication, underscores his impact in reshaping treatment paradigms. Beyond renal cancer, Kelekis has been instrumental in refining image-guided tumor ablation protocols and exploring combination therapies, earning him recognition as a thought leader in interventional radiology. His research consistently emphasizes rigorous long-term follow-up and patient-centered outcomes, making his contributions essential reading for clinicians and researchers seeking to understand the evolving landscape of cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes
15 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: National and Kapodistrian University of Athens

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago